Dana dhuwit diétung saben saham Soligenix (SNGX)

Soligenix - logo grafis emiten SNGX

Soligenix, Inc. (SNGX) specializes in niche drugs for rare pathologies, which creates opportunities for high pricing power as volumes grow. Long-term US government biosecurity contracts ensure stable sales. Meanwhile, research and development capacities are fully utilized, eliminating trial downtime. Cash per share demonstrates financial stability, with the metric holding around 0.39.

Dana dhuwit saben saham Soligenix Inc (SNGX): kanggo periode 04.07.2022 - 20.11.2026

Rincian metrik komprehensif lan analitis Soligenix (SNGX)

- rega saiki lan proyeksi nilai saham:
- indikator anane dhuwit lan arus kas:
Ringkesan analisis perusahaan:SNGX - Soligenix
Produk merek soligenix.com

This indicator reflects the volume of liquid assets per common share. Daily monitoring allows for the prompt recording of any changes in cash reserves. By analyzing the annual trend of cash per share, an investor assesses the ability of Soligenix, Inc. (SNGX) to fund a staff of leading biodefense experts and researchers. Steady growth in this metric confirms the effectiveness of government contracts, ensuring the stability of the scientific environment and the long-term viability of the business.